Abstract Aim The “2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic
Disease” provides recommendations to guide clinicians in the diagnosis, genetic evaluation …

Aortic coarctation accounts for 6% to 8% of all congenital heart disease 1 and occurs with an
incidence of 3 to 4 cases out of 10,000 live births with a male predominance of 2: 1. 2 It is …

1.1. Purpose The European Society for Vascular Surgery (ESVS) appointed the Descending
Thoracic Aorta (DTA) Writing Committee (WC) to produce the current clinical practice …

Coarctation of the aorta (CoA) accounts for approximately 5–8% of all congenital heart
defects. Depending on the severity of the CoA and the presence of associated cardiac …

Aims Coarctation of the aorta (CoA) accounts for 4–8% of congenital heart defects (CHDs)
and confers substantial morbidity despite treatment. It is increasingly recognized as a highly …

Congenital heart disease is the most common congenital defect observed in newborns.
Within the spectrum of congenital heart disease are left‐sided obstructive lesions (LSOLs) …

The optimal course of intervention for patients with coexisting coarctation of the aorta (COA)
and mixed valvular disease (combinations of aortic and mitral valve pathologies, MVD) is an …

Background: Bicuspid aortic valve (BAV) is the most prevalent congenital heart defect
affecting 1% to 2% of the population. It is associated with ascending aorta dilatation. Valve …

Coarctation of the aorta (Coa) is a potentially life threatening diagnosis. It occurs in 0.3 per
1000 live births and accounts for 6-8% of all infants with congenital heart defects. Neonates …

• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …